Non-core OTC brands of GlaxoSmithKline in Europe
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Non-core OTC brands of GlaxoSmithKline in Europe - overview
Location
Middlesex, -, UK
Primary Industry
Pharmaceuticals
About
Based in Middlesex, UK, Non-core OTC brands of GlaxoSmithKline in Europe are a portfolio of non-core over-the-counter products of GlaxoSmithKline, a UK pharmaceutical firm. In 2011, the non-core OTC brands’ sales totalled around GBP 185 million. In June 2012, Omega Pharma acquired the non-core OTC brands from GlaxoSmithKline for EUR 470 million in cash. The non-core OTC brands of GlaxoSmithKline in Europe include hay fever spray Beconase, painkiller Solpadeine, Zantac for stomach acid, Lactacyd, Abtei and Nytol for supplements and feminine hygiene product lines.
Current Investors
Omega Pharma
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.gsk.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Non-core OTC brands of GlaxoSmithKline in Europe - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Non-core OTC brands of GlaxoSmithKline in Europe | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.